Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hahn Urges Fixed Terms For US FDA Leaders

Mar 29 2021

• By Derrick Gingery

US COVID-19 response — Stephen Hahn said in the interview that decisions on hydroxychloroquine were correct at the time they were made. • Source: Shutterstock

Related Content

Moderna CEO Pushes Back On Trump Debate Comments On COVID Vaccine, Offers Own Timeline

Sep 30 2020

US FDA Independence May Be In The Eye Of The Beholder

Mar 25 2021

Former US FDA Commissioners Try To Shake Loose Biden Nomination

Mar 09 2021

Campaign Against Woodcock’s US FDA Commissioner Bid Has Begun

Jan 29 2021

BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA

Jul 04 2011

FDA Reform Bill Gives Commissioner Fixed Term, Adds Review Board

Nov 14 2011

IoM Report Blames FDA Leadership Crisis For Failure To Improve Drug Safety

Oct 02 2006

US FDA Finds There’s No Vaccine Against Politics

Dec 14 2020

Woodcock Has Big, Quiet Supporter In Her Bid For US FDA Commissioner

Feb 06 2021

Renewed Political Pressure on Hydroxychloroquine for COVID Highlights Need For Independent US FDA

Jul 08 2020

GAO To Investigate Trump Admin Attacks On Scientific Integrity At FDA, CDC

Oct 21 2020

Related Companies

Pfizer Inc.

BioNTech SE

Additional Topics

United States Coronavirus COVID-19 Leadership FDA Regulation Vaccines BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window